Breaking News

Pharmaron Acquires Biomanufacturing Site in the UK from AbbVie

Continues to build integrated capabilities platform for cell and gene therapy.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Pharmaron Beijing has entered into a definitive agreement to acquire Allergan Biologics Limited (ABL) in Liverpool, UK, for $118.7 million from AbbVie. The transaction is expected to close in the second quarter of 2021, subject to the satisfaction of customary closing conditions. The ABL site consists of a state-of-the-art, flexible cGMP biomanufacturing facility located in Liverpool with over 150 staff. Leveraging the industry-leading expertise in the process R&D, cGMP manufacturing and ad...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters